Boss reveals how to pick a 'winner'

Ex-pharma exec turned venture capitalist, Andrew Wilks, says local commercial opportunities need to be better understood after GSK scored FDA approval for a bone marrow cancer drug he discovered.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here